Please assess the completion status of the following clinical trial:

Trial Title: Antiplatelet Therapy Guided by Thrombelastography in Patients With Acute Coronary Syndromes (TEGCOR Study)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients admitted with acute coronary syndrome (unstable angina, non-ST elevation myocardial infarction) and referred for coronary angiography.~* Current therapy with clopidogrel (at least 300mg loading dose, or 75mg po daily for \>5 days)~* Age range 21-75 years.~Exclusion Criteria:~* Unable to give consent~* Age younger than 21 years, greater than 75 years~* History of stroke~* Body weight \<60 kg~* Acute STEMI,~* Thrombocytopenia\<100'000,~* requirement for chronic warfarin therapy

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- TEG (Type: OTHER): Clopidogrel non-response defined as MA≥69 Clopidogrel response defined as MA\<69
- Light transmittance aggregometry (Type: OTHER): Clopidogrel non-response defined as MPA ADP \>42.9% Clopidogrel response defined as MPA ADP \<42.9%

Based on this trial design, predict the completion outcome and termination type (if applicable).